$15.24
-0.08-0.52%
At close: Sep 9, 5:00 PM EST
$15.24
-0.08-0.52%
Pre-Market: 6:52 AM EST
AngioDynamics Inc
ANGONASDAQ
AngioDynamics Earnings & Forecasts
AngioDynamics (ANGO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
AngioDynamics Guidance
AngioDynamics (ANGO) last issued guidance on July 14, 2026 for fiscal year 2027. The company guided earnings per share in the range of $-0.29 - $-0.24, compared to a consensus EPS estimate of $-0.19. AngioDynamics also guided revenue in the range of $336M - $341M for the period.
Compared to prior guidance, AngioDynamics raised its revenue forecast from a prior range of $313.5M - $315.5M.
AngioDynamics has issued 18 guidance updates between October 6, 2022 and July 14, 2026. During this period, the company raised its outlook 7 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.09 | $-0.11 | $-0.10 | $-0.13 |
| Actual | $-0.07 | $-0.07 | $0.00 | $-0.10 |
| Surprise | +22.2% | +36.4% | +100.0% | +23.1% |
| Revenue | ||||
| Estimate | $80.3M | $77.0M | $76.3M | $72.5M |
| Actual | $86.6M | $78.4M | $79.4M | $75.7M |
| Surprise | +7.87% | +1.83% | +4.13% | +4.39% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.11 | $-0.08 | $-0.05 |
| Revenue | |||
| Consensus | $80.6M | $83.6M | — |
